Supriya Lifescience Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
|
|
|
|
|
|
|
|
|
Particulars | Mar '2025 | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 |
---|---|---|---|---|---|
Debt-Equity Ratio | 0.01 | 0.02 | 0.04 | 0.11 | 0.37 |
Long Term Debt-Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Current Ratio | 3.99 | 4.11 | 4.33 | 2.86 | 1.46 |
Fixed Assets | 1.73 | 1.91 | 1.95 | 3.40 | 3.62 |
Inventory | 7.68 | 6.44 | 4.96 | 7.14 | 7.07 |
Debtors | 6.36 | 6.59 | 5.17 | 6.24 | 6.89 |
Interest Cover Ratio | 138.28 | 33.17 | 41.09 | 50.35 | 42.01 |
PBIDTM (%) | 34.62 | 28.85 | 26.79 | 37.65 | 41.34 |
PBITM (%) | 32.01 | 26.41 | 24.50 | 35.93 | 39.77 |
PBDTM (%) | 34.39 | 28.06 | 26.20 | 36.93 | 40.39 |
CPM (%) | 26.65 | 20.86 | 19.69 | 27.51 | 30.25 |
APATM (%) | 24.04 | 18.41 | 17.40 | 25.80 | 28.68 |
ROCE (%) | 27.43 | 22.05 | 18.43 | 41.97 | 55.75 |
RONW (%) | 20.74 | 15.73 | 13.67 | 34.34 | 59.18 |